Fecal metabolic signals are associated with changes in microbiota and systemic metabolic pathways in Crohn's disease. Scientific Reports. 2026.
Short Ileal Microvillus Length Phenotype Associates with Progression from Inflammatory to Complicated Disease Behavior in Pediatric Crohn's Disease. Inflammatory Bowel Diseases. 2026; 32(2):314-327.
Prediction and Prevention of Inflammatory Bowel Disease: A Call to Action. Gastroenterology. 2026; 170(2):233-239.
Timing is Everything: Lessons Learned for Building Microbiome-Based Models in Pediatric Crohn's Disease. Inflammatory Bowel Diseases. 2026.
Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations. American Journal of Roentgenology. 2026.
Implications of Model Loss and Configuration for Sparse Histological Segmentation. In: Machine Learning Methods in Biomedical Field. Springer Nature; 2026:189-217.
Supplementation with endogenous healthy gut metabolites reverses the disruptions of in vitro and ex vivo epithelial functions induced by fecal content from IBD patients. Gut Microbes. 2025; 17(1):2597568.
Toward eliminating missed important findings in fibrostenosing Crohn's disease at CT and MR enterography. Abdominal Radiology. 2025.
Missed strictures and penetrating complications on CT and MR enterography in Crohn's disease patients prior to anti-TNF therapy. Abdominal Radiology. 2025.
Acute pancreatitis gut dysbiosis persists at 1-year follow-up and is associated with clinical outcomes. Journal of Pediatric Gastroenterology and Nutrition. 2025; 81(3):690-698.
Comparison of volumetric and linear measurements of intestinal inflammation and treatment response in children with newly diagnosed ileal Crohn disease. European Radiology. 2025; 35(8):5064-5072.
Starvation activates ECM-remodeling gene transcription and putative enhancers in fibroblasts despite inducing quiescence. Cell reports. 2025; 44(7):115896.
Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn's disease: a cohort study. Pediatric Radiology. 2025; 55(8):1642-1651.
Islet Autoantibodies and Their Association With β-Cell Function and Diabetes Measures in Children With Acute Recurrent and Chronic Pancreatitis. Diabetes Care. 2025; 48(6):974-981.
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease. Inflammatory Bowel Diseases. 2025; 31(5):1380-1391.
1121: ISLET AUTOANTIBODIES ARE ASSOCIATED WITH β CELL FUNCTION AND DIABETES MEASURES IN CHILDREN WITH ACUTE RECURRENT AND CHRONIC PANCREATITIS. Gastroenterology. 2025; 169(1):s-271-s-272.
Su1960: MULTI-OMICS ANALYSIS OF CROHN’S DISEASE TRAJECTORY FROM ACTIVE TO REMISSION REVEALS THAT DURING REMISSION, ALTERED ILEAL ANTI-BACTERIAL EPITHELIAL SIGNALS AND PATHOGENIC MICROBIOME AND METABOLOMICS PERSIST DESPITE NORMALIZING ILEAL IMMUNE SIGNALS. Gastroenterology. 2025; 169(1):s-908-s-909.
AN EVALUATION OF ENDOSCOPIC HEALING IN PEDIATRIC CROHN’S DISEASE USING MULTIPLE ENDOSCOPIC SCORING METHODS IDENTIFIES SIMILARITIES IN BLOOD AND STOOL BIOMARKERS. Inflammatory Bowel Diseases. 2025; 31(Supplement_1):s59-s60.
Eicosatetraynoic Acid Regulates Profibrotic Pathways in an Induced Pluripotent Stem Cell-Derived Macrophage-Human Intestinal Organoid Model of Crohn's Disease. Journal of Crohn's and Colitis. 2025; 19(2).
Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease. Gastroenterology. 2025; 168(2):385-388.e3.
AN EVALUATION OF ENDOSCOPIC HEALING IN PEDIATRIC CROHN’S DISEASE USING MULTIPLE ENDOSCOPIC SCORING METHODS IDENTIFIES SIMILARITIES IN BLOOD AND STOOL BIOMARKERS. Gastroenterology. 2025; 168(3):s84-s85.
P1314 Multi-omics analysis of Crohn’s Disease trajectory from active to remission reveals that the altered ileal anti-bacterial epithelial signals and pathogenic microbial composition and metabolomics persist despite normalizing ileal immune signals during remission. Journal of Crohn's and Colitis. 2025; 19(Supplement_1):i2365-i2367.
Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn's disease. Cell Host and Microbe. 2025; 33(1):71-88.e9.
Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicenter Prospective Cohort Study. Gastroenterology. 2025; 168(1):150-153.e4.
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease. Gastroenterology. 2025; 168(1):99-110.e2.
Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem Cells. Cellular and Molecular Gastroenterology and Hepatology (CMGH). 2025; 19(4):101444.
Crohn's Patients and Healthy Infants Share Immunodominant B Cell Response to Commensal Flagellin Peptide Epitopes. Gastroenterology. 2024; 167(7):1415-1428.
The role of pancreatitis risk genes in diabetes development post index admission of acute pancreatitis in children. Pancreatology. 2024; 24:e10-e11.
STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis. JCI Insight. 2024; 9(22).
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's Disease. Inflammatory Bowel Diseases. 2024; 30(11):2181-2190.
Imaging and clinical predictors of surgery in stricturing ileal Crohn's disease: a retrospective study from a large pediatric hospital. Abdominal Radiology. 2024; 49(10):3354-3363.
Prospective characterization of intestinal MRI intravoxel incoherent motion in pediatric and young adult patients with newly diagnosed small bowel Crohn's disease. Abdominal Radiology. 2024; 49(10):3325-3336.
The Role of Pancreatitis Risk Genes in Endocrine Insufficiency Development After Acute Pancreatitis in Children. Clinical Gastroenterology and Hepatology. 2024; 22(10):2033-2043.e2.
Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial Project. Clinical Gastroenterology and Hepatology. 2024; 22(9):1889-1897.e12.
Duodenal quantitative mucosal morphometry in children with environmental enteric dysfunction: a cross-sectional multicountry analysis. American Journal of Clinical Nutrition. 2024; 120 Suppl 1(Suppl 1):S41-S50.
Duodenal transcriptomics demonstrates signatures of tissue inflammation and immune cell infiltration in children with environmental enteric dysfunction across global centers. American Journal of Clinical Nutrition. 2024; 120 Suppl 1(Suppl 1):S51-S64.
Anthropometry relationship with duodenal histologic features of children with environmental enteric dysfunction: a multicenter cross-sectional study. American Journal of Clinical Nutrition. 2024; 120 Suppl 1:S65-S72.
The Environmental Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium: mucosal investigations of environmental enteric dysfunction. American Journal of Clinical Nutrition. 2024; 120 Suppl 1:S4-S14.
Histopathology underlying environmental enteric dysfunction in a cohort study of undernourished children in Bangladesh, Pakistan, and Zambia compared with United States children. American Journal of Clinical Nutrition. 2024; 120 Suppl 1:S15-S30.
Multiplexed immunohistochemical evaluation of small bowel inflammatory and epithelial parameters in environmental enteric dysfunction. American Journal of Clinical Nutrition. 2024; 120 Suppl 1:S31-S40.
Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism. Inflammatory Bowel Diseases. 2024; 30(8):1379-1388.
Machine-learning-based integrative -'omics analyses reveal immunologic and metabolic dysregulation in environmental enteric dysfunction. iScience. 2024; 27(6):110013.
Ileal Crohn's Disease Exhibits Reduced Activity of Phospholipase C-β3-Dependent Wnt/β-Catenin Signaling Pathway. Cells. 2024; 13(11).
Pilot and feasibility of the SMART IBD mobile app to improve self-management in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2024; 78(6):1273-1278.
Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort. Nature Communications. 2024; 15(1):3764.
Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response Using Diagnostic Histopathology. Gastroenterology. 2024; 166(5):921-924.e4.
958 ATTAINING EARLY ANTI-TNF EXPOSURE TARGETS IS ASSOCIATED WITH IMPROVED RATES OF ENDOSCOPIC HEALING AND TRANSMURAL HEALING IN CHILDREN WITH CROHN'S DISEASE. Gastroenterology. 2024; 166(5):s-226-s-227.
748 EXTENSIVE PROTEOMIC ANALYSIS IDENTIFIES A CROHN'S DISEASE CORE PROTEOME AND ANTI-TNF TREATMENT RESPONSE PROFILE FOR CHILDREN WITH CROHN'S DISEASE. Gastroenterology. 2024; 166(5):s-177-s-178.
Mo1794 CROHN'S DISEASE-ASSOCIATED PATHOGENIC MUTATION IN MANGANESE TRANSPORTER ZIP8 SHIFTS THE ILEAL AND RECTAL MUCOSAL MICROBIOTA IMPLICATING ABERRANT BILE ACID METABOLISM. Gastroenterology. 2024; 166(5):s-1114.
Fitness-for-use of Retrospective Multicenter Electronic Health Records to Conduct Outcome Analysis for Pediatric Ulcerative Colitis. Medicine (United Kingdom). 2024; 103(11):e37395.
Acute pancreatitis is associated with gut dysbiosis in children. Digestive and Liver Disease. 2024; 56(3):444-450.
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course. Cell Host and Microbe. 2024; 32(2):209-226.e7.
Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity. 2024; 57(2):319-332.e6.
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clinical Gastroenterology and Hepatology. 2024; 22(2):368-376.e4.
MRI AND BLOOD-BASED BIOMARKERS ASSOCIATED WITH SURGICAL MANAGEMENT IN CHILDREN AND ADULTS WITH SMALL BOWEL CROHN'S DISEASE. Gastroenterology. 2024; 166(3):s19-s20.
Administration of Human Milk Oligosaccharide (2′-fucosyllactose) Reduces Dysbiosis and Increases Short Chain Fatty Acids in Children and Young Adults Following HSCT: A Prospective, Single-Center Study. Transplantation and Cellular Therapy. 2024; 30(2):s16.
MRI AND BLOOD-BASED BIOMARKERS ASSOCIATED WITH SURGICAL MANAGEMENT IN CHILDREN AND ADULTS WITH SMALL BOWEL CROHN'S DISEASE. Inflammatory Bowel Diseases. 2024; 30(Supplement_1):s14-s15.
P067 Volumetric Assessment of Treatment Response in Newly Diagnosed Crohn Disease: A Pilot Study. Journal of Crohn's and Colitis. 2024; 18(Supplement_1):i333-i333.
Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia. Genes and Diseases. 2024; 11(1):413-429.
Machine Learning Diagnosis of Small-Bowel Crohn Disease Using T2-Weighted MRI Radiomic and Clinical Data. American Journal of Roentgenology. 2024; 222(1):e2329812.
Self-Management assistance for recommended treatment (SMART) IBD app randomized control trial in adolescents with IBD: Design and methodology. Health Care Transitions. 2024; 2:100031.
A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy. PLoS ONE. 2024; 19(3):e0295814.
De Novo Crohn's Disease Diagnosed in the Setting of Acute SARS-Cov-2 Infection Requiring Escalation of Infliximab Therapy Guided by Personalized Pharmacokinetics. J Pediatr Perinatol Child Health. 2024; 8(1):1-4.
Microbiota-derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient-derived colonoids. Neurogastroenterology and Motility. 2023; 35(12):e14681.
Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease. Scientific Reports. 2023; 13(1):20513.
Acute pancreatitis is associated with gut dysbiosis in children. Pancreatology. 2023; 23:e3-e4.
Integrative –‘Omics and Machine-Learning-Based Image Analyses of Environmental Enteric Dysfunction Reveal an Immunologic and Metabolic Pathogenesis of Intestinal Failure. . 2023.
Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood advances. 2023; 7(17):5137-5151.
Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. Journal of Pediatrics. 2023; 260:113522.
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives. Gastroenterology. 2023; 165(3):670-681.
Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease. JCI Insight. 2023; 8(14).
Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica. 2023; 108(7):1803-1816.
The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation. Neurogastroenterology and Motility. 2023; 35(7):e14573.
GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis. 2023; 17(6):960-971.
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023; 21(5):1338-1347.
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nature Genetics. 2023; 55(5):796-806.
783 DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. 2023; 164(6):s-170.
Su1013 EVALUATION OF INSURANCE TYPE ON PRIOR AUTHORIZATION (PA) DELAYS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS PRESCRIBED BIOLOGIC THERAPIES. Gastroenterology. 2023; 164(6):s-504-s-505.
Su1884 ACUTE PANCREATITIS IS ASSOCIATED WITH GUT DYSBIOSIS IN CHILDREN. Gastroenterology. 2023; 164(6):s-703.
675 EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN'S DISEASE. Gastroenterology. 2023; 164(6):s-132-s-133.
Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. Nature Communications. 2023; 14(1):2256.
DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. 2023; 164(4):s72-s73.
EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology. 2023; 164(4):s97-s98.
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis. Gastroenterology. 2023; 164(4):619-629.
Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC. Clinical Epigenetics. 2023; 15(1):50.
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology and Therapeutics. 2023; 57(5):524-539.
Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2023; 29(2):286-296.
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory Bowel Diseases. 2023; 29(2):328-331.
DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 2023; 29(Supplement_1):s56-s57.
EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases. 2023; 29(Supplement_1):s76-s77.
Ultrasound shear wave elastography in pediatric stricturing small bowel Crohn disease: correlation with histology and second harmonic imaging microscopy. Pediatric Radiology. 2023; 53(1):34-45.
The Simplified MR Index of Activity Score in Pediatric Small-Bowel Crohn Disease: An Interreader Agreement and Responsiveness Study. American Journal of Roentgenology. 2023; 220(1):126-133.
Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 2023; 76(1):38-42.
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. Journal of Crohn's and Colitis. 2022; 16(11):1735-1750.
Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction. Nature Biomedical Engineering. 2022; 6(11):1236-1247.
Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation. Matrix Biology. 2022; 113:1-21.
MRI-Based Characterization of Intestinal Motility in Children and Young Adults With Newly Diagnosed Ileal Crohn Disease Treated by Biologic Therapy: A Controlled Prospective Study. American Journal of Roentgenology. 2022; 219(4):655-664.
Bowel wall MRI T1 relaxation estimates for assessment of intestinal inflammation in pediatric Crohn's disease. Abdominal Radiology. 2022; 47(8):2730-2738.
Velocity-Encoded Phase-Contrast MRI for Measuring Mesenteric Blood Flow in Patients With Newly Diagnosed Small-Bowel Crohn Disease. American Journal of Roentgenology. 2022; 219(1):132-141.
Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures. Inflammatory Bowel Diseases. 2022; 28(7):988-1003.
Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention. Patient Education and Counseling. 2022; 105(5):1075-1081.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162(6):1635-1649.
Sa1590: RADIOGRAPHIC PROGRESSION AND THE EFFECT OF ANTI-TUMOR NECROSIS FACTOR IN CHILDREN WITH TREATMENT NAÏVE CROHN'S DISEASE. Gastroenterology. 2022; 162(7):s-428-s-429.
Methylation quantitative trait loci are largely consistent across disease states in Crohn's disease. G3: Genes, Genomes, Genetics. 2022; 12(4).
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 2022; 55(5):593-603.
Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biology. 2022; 23(1):61.
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflammatory Bowel Diseases. 2022; 28(2):151-160.
EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology. 2022; 162(3):s62-s63.
REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Gastroenterology. 2022; 162(3):s100.
EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases. 2022; 28(Supplement_1):s62-s63.
REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Inflammatory Bowel Diseases. 2022; 28(Supplement_1):s100-s100.
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 2022; 74(1):72-78.
Mucosal microbiome is predictive of pediatric Crohn's disease across geographic regions in North America. F1000Research. 2022; 11:156.